Development of an ultrasonic nonlinear frequency compounding method with applications in tissue thermometry

Ultrasound-mediated nano-sized drug delivery systems for cancer treatment: Multi-scale and multi-physics computational modeling

Computational modeling enables researchers to study and understand various complex biological phenomena in anticancer drug delivery systems (DDSs), especially nano-sized DDSs (NSDDSs). The combination of NSDDSs and therapeutic ultrasound (TUS), that is, focused ultrasound and low-intensity pulsed ultrasound, has made significant progress in recent years, opening many opportunities for cancer treatment. Multiple parameters require tuning and optimization to develop effective DDSs, such as NSDDSs, in which mathematical modeling can prove advantageous. In silico computational modeling of ultrasound-responsive DDS typically involves a complex framework of acoustic interactions, heat transfer, drug release from nanoparticles, fluid flow, mass transport, and pharmacodynamic governing equations. Owing to the rapid development of computational tools, modeling the different phenomena in multi-scale complex problems involved in drug delivery to tumors has become possible. In the present study, we present an in-depth review of recent advances in the mathematical modeling of TUS-mediated DDSs for cancer treatment. A detailed discussion is also provided on applying these computational models to improve the clinical translation for applications in cancer treatment. This article is categorized under: Nanotechnology Approaches to Biology > Nanoscale Systems in Biology Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease.

Decorrelated compounding of synthetic aperture ultrasound imaging to detect low contrast thermal lesions induced by focused ultrasound

PURPOSE

Decorrelated Compounding (DC) for synthetic aperture ultrasound can reduce speckle variation in images, suggesting enhanced detectability of low-contrast targets in tissue including thermal lesions produced by focused ultrasound (FUS). The DC imaging method has primarily been investigated in simulation and in phantom studies. This work investigates the feasibility of the DC method in monitoring thermal therapy via image guidance and non-invasive thermometry based on the change in backscattered energy (CBE).

METHODS

Ex vivo porcine tissue was exposed to FUS exposures at acoustic powers of 5 W and 1 W, with peak pressure amplitudes of 0.64 MPa and 0.27 MPa respectively. During FUS exposure, RF echo data frames was acquired using a 7.8 MHz linear array probe and a Verasonics Vantage^TM ultrasound scanner (Verasonics Inc., Redmond, WA). RF echo data was taken to produce B-mode images, as reference images. Synthetic aperture RF echo data was also acquired and processed using delay-and-sum (DAS), a combination of spatial and frequency compounding referred to as Traditional Compounding (TC), and the proposed DC imaging methods. Image quality was assessed using the contrast-to-noise ratio (CNR) at the FUS beam focus, and the speckle SNR (sSNR) of the background region as preliminary metrics. A calibrated thermocouple was placed near the FUS beam focus for temperature measurements and calibrations using the CBE method.

RESULTS

The DC imaging method significantly improved image quality to detect low contrast thermal lesions in treated ex vivo porcine tissue in comparison to other imaging methods. In comparison to B-mode imaging, the lesion CNR measured using the DC imaging was shown to improve up to a factor of approximately 5.5. The corresponding sSNR improved by a factor of approximately 4.2 in comparison to B-mode imaging. CBE calculation using the DC imaging method yielded more precise measurements of the backscattered energy compared to other imaging methods studied.

CONCLUSIONS

The despeckling performance of the DC imaging method significantly improves the lesion CNR in comparison to B-mode imaging. This suggests that the proposed method can detect low-contrast thermal lesions induced by FUS therapy that are not detectable using standard B-mode imaging. Furthermore, the signal change at the focal point were more precisely measured by DC imaging, and the signal change in response to FUS exposure follows the temperature profile more closely than changes measured using B-mode, as well as synthetic aperture DAS and TC images. These suggest that DC imaging can potentially be used with the CBE method to improve non-invasive thermometry.

Ultrasound-mediated nano drug delivery for treating cancer: Fundamental physics to future directions

The application of biocompatible nanocarriers in medicine has provided several benefits over conventional treatment methods. However, achieving high treatment efficacy and deep penetration of nanocarriers in tumor tissue is still challenging. To address this, stimuli-responsive nano-sized drug delivery systems (DDSs) are an active area of investigation in delivering anticancer drugs. While ultrasound is mainly used for diagnostic purposes, it can also be applied to affect cellular function and the delivery/release of anticancer drugs. Therapeutic ultrasound (TUS) has shown potential as both a stand-alone anticancer treatment and a method to induce targeted drug release from nanocarrier systems. TUS approaches have been used to overcome various physiological obstacles, including endothelial barriers, the tumor microenvironment (TME), and immunological hurdles. Combining nanomedicine and ultrasound as a smart DDS can increase in situ drug delivery and improve access to impermeable tissues. Furthermore, smart DDSs can perform targeted drug release in response to distinctive TMEs, external triggers, or dual/multi-stimulus. This results in enhanced treatment efficacy and reduced damage to surrounding healthy tissue or organs at risk. Integrating DDSs and ultrasound is still in its early stages. More research and clinical trials are required to fully understand ultrasound's underlying physical mechanisms and interactions with various types of nanocarriers and different types of cells and tissues. In the present review, ultrasound-mediated nano-sized DDS, specifically focused on cancer treatment, is presented and discussed. Ultrasound interaction with nanoparticles (NPs), drug release mechanisms, and various types of ultrasound-sensitive NPs are examined. Additionally, in vitro, in vivo, and clinical applications of TUS are reviewed in light of the critical challenges that need to be considered to advance TUS toward an efficient, secure, straightforward, and accessible cancer treatment. This study also presents effective TUS parameters and safety considerations for this treatment modality and gives recommendations about system design and operation. Finally, future perspectives are considered, and different TUS approaches are examined and discussed in detail. This review investigates drug release and delivery through ultrasound-mediated nano-sized cancer treatment, both pre-clinically and clinically.

Multiphysics Modeling of Low-Intensity Pulsed Ultrasound Induced Chemotherapeutic Drug Release from the Surface of Gold Nanoparticles

Currently, no numerical model for low-intensity pulsed ultrasound (LIPUS)-triggered anticancer drug release from gold nanoparticle (GNP) drug carriers exists in the literature. In this work, LIPUS-induced doxorubicin (DOX) release from GNPs was achieved in an ex vivo tissue model. Transmission electronic microscopy (TEM) imaging was performed before and after LIPUS exposure, and significant aggregation of the GNPs was observed upon DOX release. Subsequently, GNP surface potential was determined before and after LIPUS-induced DOX release, using a Zetasizer. A numerical model was then created to predict GNP aggregation, and the subsequent DOX release, via combining a thermal field simulation by solving the bioheat transfer equation (in COMSOL) and the Derjaguin, Landau, Verwey, and Overbeek (DLVO) total interaction potential (in MATLAB). The DLVO model was applied to the colloidal DOX-loaded GNPs by summing the attractive van der Waals and electrostatic repulsion interaction potentials for any given GNP pair. DLVO total interaction potential was found before and after LIPUS exposure, and an energy barrier for aggregation was determined. The DLVO interaction potential peak amplitude was found to drop from 1.36 k_BT to 0.24 k_BT after LIPUS exposure, translating to an 82.4% decrease in peak amplitude value. It was concluded that the interaction potential energy threshold for GNP aggregation (and, as a result, DOX release) was equal to 0.24 k_BT.